The latest price target for NeueHealth (NYSE:NEUE) was reported by RBC Capital on March 13, 2024. The analyst firm set a price target for $8.00 expecting NEUE to rise to within 12 months (a possible 54.14% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for NeueHealth (NYSE:NEUE) was provided by RBC Capital, and NeueHealth maintained their sector perform rating.

There is no last upgrade for NeueHealth

There is no last downgrade for NeueHealth.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NeueHealth, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NeueHealth was filed on March 13, 2024 so you should expect the next rating to be made available sometime around March 13, 2025.

While ratings are subjective and will change, the latest NeueHealth (NEUE) rating was a maintained with a price target of $7.00 to $8.00. The current price NeueHealth (NEUE) is trading at is $5.19, which is out of the analyst’s predicted range.